News
Events
Press Releases
Careers
Contact Us
Home
About Us
Overview
Management
Board of Directors
Scientific Advisory Board
Careers
Product
Overview
RIZAPORT
®
Tadalafil
Loxapine
Montelukast
More Products
R&D Services
Overview
VersaFilm
VetaFilm
Services
Manufacturing Services
Overview
Manufacturing & Packaging
Services
Partnering
Overview
Trade Shows
BD Contacts
Investors
Overview
Shareholder Reports
Corporate Governance
Press Releases
Stock Price
Presentations
Regulatory Filings
XBRL Files
Analyst Coverage
Videos
RSS Feeds
IR Contact
Home
About Us
Overview
Management
Board of Directors
Scientific Advisory Board
Careers
Product
Overview
RIZAPORT<sup>®</sup>
Tadalafil
Loxapine
Montelukast
More Products
R&D Services
Overview
VersaFilm
VetaFilm
Services
Manufacturing Services
Overview
Manufacturing & Packaging
Services
Partnering
Overview
Trade Shows
BD Contacts
Investors
Overview
Shareholder Reports
Corporate Governance
Press Releases
Stock Price
Presentations
Regulatory Filings
XBRL Files
Analyst Coverage
Videos
RSS Feeds
IR Contact
INTELGENX
Home
>
Investors
>
Regulatory Filings
>
SEC Filings Details
INTELGENX
Home
>
Investors
>
Regulatory Filings
>
SEC Filings Details
SEC Filings Details
11/12/2009
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Home
About Us
Overview
Management
Board of Directors
Scientific Advisory Board
Careers
Product
Overview
RIZAPORT
®
Tadalafil
Loxapine
Montelukast
More Products
R&D Services
Overview
VersaFilm
VetaFilm
Services
Manufacturing Services
Overview
Manufacturing & Packaging
Services
Partnering
Overview
Trade Shows
BD Contacts
Investors
Overview
Shareholder Reports
Corporate Governance
Press Releases
Stock Price
Presentations
Regulatory Filings
XBRL Files
Analyst Coverage
Videos
RSS Feeds
IR Contact
Shareholder Tools
Financial Reports
E-mail Alerts
RSS News Feeds
About us
Product
R&D Services
Manufacturing Services
Partnering
Investors
More Links
Facebook
Twitter
Linkedin
© Copyright 2017. IntelGenx Corp. All Rights Reserved.
Terms of Service
Privacy
Powered By Q4 Inc.
5.21.0.2